Here's what we'll cover
Here's what we'll cover
On September 1, 2026, the Wegovy pill went on sale in German pharmacies, making Germany the first European Union country where Novo Nordisk has launched its oral weight loss medicine, according to Euronews and Reuters reporting.
For US readers, one point matters most: this is not a preview of something coming to America. The Wegovy pill has been FDA approved since December 2025 and has been sold in the United States since early 2026. Germany is catching up, not leading.
What Is the Wegovy Pill?
The Wegovy pill is a once daily tablet containing semaglutide, the same active ingredient as the weekly Wegovy injection and Ozempic. It is approved for chronic weight management in adults with obesity, or with overweight plus at least one weight related condition, alongside diet and physical activity.
The maintenance dose is 25 mg daily, reached after starting doses of 1.5 mg, 4 mg, and 9 mg. Swallowed semaglutide is absorbed far less efficiently than injected semaglutide, which is why tablet doses are much higher in milligrams. The tablet uses an absorption enhancer called SNAC to help the drug pass through the stomach lining.
How It Is Taken
Absorption depends on following the instructions closely:
- Take it first thing in the morning on an empty stomach
- Swallow it with a small sip of plain water, no more than about 4 ounces
- Wait at least 30 minutes before eating, drinking anything else, or taking other oral medicines
- Swallow the tablet whole
What the Research Shows
The 25 mg tablet was approved based largely on the OASIS 4 trial, published in the New England Journal of Medicine in 2025. Adults taking oral semaglutide 25 mg lost an average of 13.6% of body weight over 64 weeks, compared with 2.2% on placebo, as summarized by AJMC. Among people who stayed on treatment as directed, average loss was about 16.6%.
For comparison, injectable semaglutide 2.4 mg produced about 15% weight loss over 68 weeks in STEP 1. An earlier trial of a higher 50 mg oral dose, OASIS 1, showed similar results to the injection but that dose was not the one brought to market.
Side effects mirror the injection: nausea, diarrhea, vomiting, and constipation, mostly during dose increases.
Where the Wegovy Pill Is Available
| Market | Status as of October 2026 |
|---|---|
| United States | FDA approved December 2025; launched early 2026 |
| United Kingdom | Available through private and online pharmacies; NHS use under review |
| United Arab Emirates | Launched earlier in 2026 |
| European Union | Approved by the European Commission in July 2026 |
| Germany | On sale since September 1, 2026; first EU launch |
Novo Nordisk has said it plans to launch in additional countries, but it has not named them, according to FoodNavigator.
What It Costs in Germany
A Novo Nordisk spokesperson said German pharmacy prices are expected to range from about 170 to 280 euros per month depending on dose, comparable to the Wegovy pen, according to Euronews. Germany's statutory health insurance generally does not pay for medicines used primarily for weight loss, so most patients there are expected to pay out of pocket. A prescription is still required.
What It Costs in the United States
US pricing has moved quickly. Manufacturer self pay programs launched the starting doses of the Wegovy pill at about $149 per month, with higher doses costing more, according to Fierce Pharma. Eli Lilly's competing pill, Foundayo (orforglipron), was approved in April 2026 at a similar starting price. Insurance coverage varies by plan, and many employer plans still exclude weight loss drugs.
Before paying full price, check manufacturer programs and current GLP-1 coupons and savings programs.
Pill or Injection: How to Think About It
Neither format is right for everyone. The pill avoids needles and refrigeration, which matters to many people. The injection is once weekly with no fasting routine, and the 2.4 mg dose has the longest track record, including a cardiovascular indication.
- Choose based on what you will take consistently, not just the format
- Consider your morning routine, since the pill needs a 30 minute wait before food or other medicines
- Compare out of pocket costs for your specific dose and coverage
- Ask whether switching would require restarting at a lower dose
Questions to Ask Your Doctor
- Is the Wegovy pill a reasonable option for me, given my other morning medications?
- How would my expected results compare with the injection?
- If I switch from the injection to the pill, what dose would I start on?
- Which format does my insurance cover, and what would I pay?
No waiting list. No insurance needed.
Frequently Asked Questions
When did the Wegovy pill launch in Germany?
The Wegovy pill went on sale in German pharmacies on September 1, 2026, making Germany the first European Union country where Novo Nordisk launched it after EU approval in July 2026.
Is the Wegovy pill available in the United States?
Yes. The FDA approved oral semaglutide 25 mg as the Wegovy pill in December 2025, and it launched in the United States in early 2026. A prescription is required.
How much does the Wegovy pill cost in Germany?
Novo Nordisk said German pharmacy prices are expected to range from about 170 to 280 euros per month depending on dose. Statutory insurance generally does not cover weight loss medicines, so most patients pay out of pocket.
How much weight can you lose on the Wegovy pill?
In the OASIS 4 trial, adults taking oral semaglutide 25 mg lost an average of 13.6% of body weight over 64 weeks, compared with 2.2% on placebo.
How do you take the Wegovy pill?
Take it once daily on an empty stomach with no more than about 4 ounces of plain water, then wait at least 30 minutes before eating, drinking, or taking other oral medicines.
Is the Wegovy pill better than the injection?
Weight loss is broadly similar. The pill avoids needles but requires a daily fasting routine, while the injection is weekly with no food timing rules. The best choice is the one you can take consistently.
The Bottom Line
Germany's September 2026 launch makes it the first EU country to offer the Wegovy pill, at roughly 170 to 280 euros per month and mostly without statutory insurance coverage. For US patients, the pill is already here: it was approved in December 2025, and self pay pricing starts at about $149 per month for the lowest dose.
The tablet produced about 13.6% average weight loss in OASIS 4, close to the injection, but it requires a strict morning routine. If you are weighing the pill against the pen, talk with your prescriber about your goals, habits, and costs. To find a prescriber who offers both options, compare vetted telehealth providers. Always consult your physician before starting, stopping, or switching any GLP-1 medication.